Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

September 5, 2023

Study Completion Date

September 14, 2023

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Pirfenidone Modified-Release Tablets

take the tablet under fed condition, 1 tablet at a time, once a day.

DRUG

Pirfenidone Tablets

ake the tablet under fed condition, 1 tablet at a time, three times a day.

Trial Locations (1)

266000

The Affiliated Hospital of Qingdao University, Qingdao

Sponsors
All Listed Sponsors
lead

Overseas Pharmaceuticals, Ltd.

INDUSTRY

NCT06589921 - Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter